Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Microbiol ; 131(5): 2567-2578, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33884721

ABSTRACT

AIMS: Assess the feasibility of using light from artificial sun lamps to decontaminate N95 filtering facepiece respirators (FFRs) contaminated with SARS-CoV-2. METHODS AND RESULTS: FFR coupons or whole FFRs contaminated with 5 log10 TCID50 (target concentration) SARS-CoV-2 in culture media, simulated saliva, or simulated lung fluid were dried for 1-2 h, then exposed to light from tanning and horticulture lamps to assess decontamination. Exposed coupons and whole FFRs showed SARS-CoV-2 inactivation for all matrices tested. Furthermore, FFRs still met performance specifications after five decontamination cycles. CONCLUSIONS: It is feasible that artificial sunlight from these sun lamps can be used to decontaminate FFRs provided the UV dose is sufficient and the light is unobstructed. Furthermore, decontamination can be performed up to five times without degrading FFR performance. SIGNIFICANCE AND IMPACT OF THE STUDY: This research shows a proof of principle that artificial sun lamps may be an option to decontaminate SARS-CoV-2 on N95 FFRs. UV doses required for inactivation to levels below detection ranged from 4 to 37·8 J cm-2 depending on the light source, virus matrix and FFR type.


Subject(s)
COVID-19 , Equipment Reuse , Decontamination , Humans , N95 Respirators , SARS-CoV-2
2.
Lett Appl Microbiol ; 72(4): 366-374, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33347637

ABSTRACT

Decontamination of N95 filtering facepiece respirators (FFRs) is a crisis capacity strategy allowed when there are known shortages of FFRs. The application of moist heat is one decontamination method that has shown promise and is the approach approved in the Steris Steam Emergency Use Authorization (EUA). This effort examines the use of multicookers to apply moist heat, as they are available in retail stores and more affordable than methods requiring more sophisticated equipment. Four of five multicooker models examined met the acceptance criteria for the test and one model was selected for inactivation testing. Tests were performed on four different FFR models with SARS-CoV-2 suspended in culture media, simulated saliva or simulated lung fluid. Moist heat treatment reduced recoverable titres of SARS-CoV-2 virus to levels below the limit of detection in all tests. Furthermore, these four FFR models showed no loss in collection efficiency, inhalation resistance or visual damage after up to 10 decontamination cycles. Two (2) FFR models showed a slight change in strap elasticity (<9%). These data show that moist heat treatment using a multicooker is a viable option for FFR decontamination in a crisis capacity strategy.


Subject(s)
COVID-19/prevention & control , Decontamination/methods , Equipment Reuse , Hot Temperature , N95 Respirators , Humans , SARS-CoV-2/isolation & purification
3.
J Intellect Disabil Res ; 41 ( Pt 3): 273-7, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9219078

ABSTRACT

The existing literature regarding neuroleptic malignant syndrome (NMS) amongst people with learning disabilities is limited. We describe three case reports of people with learning disabilities from the same geographical area who developed NMS within 3 weeks of each other. This was during the hottest part of a very hot summer. The presentation of NMS is discussed. The importance of carers attending to adequate hydration for people with learning disabilities and poor communication skills during the summer months is stressed.


Subject(s)
Antipsychotic Agents/adverse effects , Hot Temperature/adverse effects , Intellectual Disability/drug therapy , Neuroleptic Malignant Syndrome/etiology , Seasons , Adolescent , Adult , Antipsychotic Agents/administration & dosage , Diagnosis, Differential , Drug Therapy, Combination , Female , Humans , Intellectual Disability/psychology , Male , Neuroleptic Malignant Syndrome/diagnosis , Neuroleptic Malignant Syndrome/prevention & control , Residential Facilities , Risk Factors
5.
Am Pharm ; NS20(10): 43-9, 1980 Oct.
Article in English | MEDLINE | ID: mdl-7435368
6.
Contemp Pharm Pract ; 3(4): 268-70, 1980.
Article in English | MEDLINE | ID: mdl-10248869

ABSTRACT

Community pharmacists can provide pharmaceutical services to the health maintenance organization (HMO) patient on a cost-effective, competitive basis. Reimbursement based on usual and customary fees has proven to be an attractive method of payment not only to the participating pharmacists, but to the HMO administration as well. State pharmaceutical associations can play an integral role in developing, administering, and monitoring the pharmaceutical component of an HMO. A sharing of the financial risk encourages pharmacists to act as prudent purchasers of the drug product to be dispensed to HMO patients.


Subject(s)
Health Maintenance Organizations , Insurance, Pharmaceutical Services , Pharmaceutical Services/economics , Minnesota
SELECTION OF CITATIONS
SEARCH DETAIL
...